Exicure (XCUR) Goodwill (2025 - 2026)
Exicure's (XCUR) quarterly Goodwill came in at $4.4 million in Q1 2026, up 31.71% YoY from $3.3 million in Q1 2025, and little changed on a QoQ basis from $4.4 million in Q4 2025.
Exicure (XCUR) Goodwill (2025 - 2026) Analysis & Trends
Exicure (XCUR) has 2 years of Goodwill data on file, last reported at $4.4 million in Q1 2026.
- Quarterly Goodwill rose 31.71% year-over-year to $4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.4 million (up 31.71% YoY) and the FY2025 annual result came in at $4.4 million, changed N/A from the prior year.
- Goodwill steadied at $4.4 million in Q1 2026, from $4.4 million in the prior quarter.
- In the past five years, Goodwill ranged from a high of $4.4 million in Q4 2025 to a low of $3.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Exicure | 8.41 Mn | 8.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.40 Mn |
| Dec 31, 2025 | 4.40 Mn |
| Sep 30, 2025 | 3.34 Mn |
| Jun 30, 2025 | 3.34 Mn |
| Mar 31, 2025 | 3.34 Mn |